Greenwich LifeSciences, Inc. (GLSI) › Operating IncomeGreenwich LifeSciences, Inc. (GLSI) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$3.43M2020: -$1.86M2021: -$4.60M2022: -$8.04M2023: -$9.33M2024: -$17.64M2025: -$19.45M-$19.45M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$19.45M-10.3%2024-$17.64M-89.1%2023-$9.33M-16.0%2022-$8.04M-74.9%2021-$4.60M-146.7%2020-$1.86M+45.6%2019-$3.43M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share